Targeted HIV Testing & Enhanced Testing Technologies. HIV Prevention Section Bureau of HIV/AIDS
|
|
|
- Lucas Cox
- 10 years ago
- Views:
Transcription
1 Targeted HIV Testing & Enhanced Testing Technologies HIV Prevention Section Bureau of HIV/AIDS May
2 Typing a Question in the Chat Box Type question in here 2
3 Completing the Webinar Evaluation (opened at end of webinar) 3
4 Introduction National HIV/AIDS Strategy High Impact Prevention New CDC HIV Prevention Grant (Cat. A vs. Cat. B) 4
5 Nat l HIV/AIDS Strategy Goals 1. Reduce the number of people who become HIV infected 2. Increase access to care and optimize health outcomes for people living with HIV 3. Reduce HIV-related health disparities, discrimination and stigma 4. Achieve a more coordinated national response to the domestic HIV epidemic 5
6 High Impact Prevention (HIP) Scientifically proven HIV prevention interventions This DOES NOT mean only DEBIs. What it does mean is the following: HIV testing and linkage to care Antiretroviral therapy Access to condoms and sterile syringes* Prevention programs for people living with HIV and their partners Prevention programs for people at high risk of HIV infection Substance abuse treatment Screening and treatment for other STIs *Syringe exchange is currently prohibited in FL due to certain paraphernalia laws. Source: Centers for Disease Control and Prevention (CDC). High-Impact HIV Prevention: CDC s Approach to Reducing HIV Infections in the United States. August Atlanta, GA. 6
7 High Impact Prevention (HIP) Populations at highest risk Gay and bisexual men of all races and ethnicities Blacks/African Americans Hispanics/Latinos Injection Drug Users Transgender Individuals Source: Centers for Disease Control and Prevention (CDC). High-Impact HIV Prevention: CDC s Approach to Reducing HIV Infections in the United States. August Atlanta, GA. 7
8 CDC HIV Prevention Grant (PS ) Category A- HIV Prevention - Required Core Components Category B- ETI Required Core Components 8
9 Epidemiologic Background & Data 9
10 Awareness of HIV Status among Persons with HIV, United States Estimated new infections 48,100 annually Number HIV infected 1,178,350 Number unaware of their HIV infection 235,670 (20%) Campsmith, M., et al, MMWR October 2008; Hall, I., et al, JAMA August
11 The Epidemic in Florida 2011 Population: 18.8 million (4 th in nation) Cumulative AIDS cases: 124,069 (3 rd in nation) Cumulative pediatric AIDS cases: 1,543 (2 nd in nation) Cumulative HIV (not AIDS) cases: 47,695 (2 nd in nation of 46 states with HIV name reporting) 60% White 16% Black 22% Hispanic 2% Other* Persons living with HIV/AIDS: 95,335 HIV prevalence estimate: 130,000 30% White 49% Black 19% Hispanic 2% Other* HIV Incidence Estimates are approximately 5,000 per year, *Other = Asian/Pacific Islanders; American Indians/Alaskan Natives; multi-racial. Trend data as of 12/31/2011, Living data as of 05/26/
12 Percent of Persons Ever Tested and Tested in the Preceding 12 Months - NHIS Ever tested Preceding 12 months Percent - MMWR August 8,
13 HIV Testing: % of adults tested for HIV at least once Estimated 71.5 million persons 10.4% tested in the preceding 12 months Estimated 17.8 million persons - Duran et al, MMWR, August
14 Early Indications of Progress Ever Tested 70,036,336 (39.9%) 71,468,420 (40.4%) 73,848,002 (41.3%) Last 12 months 18,042,610 (10.4%) 17,775,006 (10.4%) 18,791,895 (10.7%) 14
15 Persons Tested, Preceding 12 Months White Black Hispanic Risk factors? Yes No Pregnant? Yes No 8% 22% 13% 23% 10% 61% 13% -Duran et al, MMWR August 2008; 2006 National Health Survey 15
16 Where were persons tested for HIV? Private doctor/hmo Hospital, ED, Outpatient Community clinic (public) HIV counseling/testing Correctional facility STD clinic Drug treatment clinic % 22% 9% 5% 0.6% 0.1% 0.7% % 18% 9% 5% 0.4% 0.1% 0.4% National Health Interview Survey 16
17 HIV Testing among High-Risk Populations, Findings from Behavioral Surveillance in South FL MSM ( ) N=1,540 70% 94% IDUs ( ) N=934 62% 96% Heterosexuals in low-income areas (2007) N=1,224 40% 79% Tested in Past 12 Months Ever Tested Top Reasons for Not Testing in Past 12 Months (all populations) - Low risk for HIV - Afraid of finding out HIV Didn t have time
18 Testing Technologies OraSure Rapid Testing 4 th Generation 18
19 OraSure Oral fluid testing Great for outreach settings Best at identifying long-term infection 19
20 Rapid Testing Very good/accurate tests Use in lab like settings and mobile units Results in as little as 15 minutes Excellent technology for ensuring the client receives results 20
21 4 th Generation Testing Abbott Architect Ag/Ab Combination 21
22 4 th Generation Testing Blood only Antibody Looks for antibodies for HIV-1 and HIV-2 Antigen (p-24) Antigens are molecules that react with an antibody A protein found in the core structure of HIV actually part of the virus itself The test doesn t differentiate between Ag+ and Ab+ - that is determined in the confirmatory test 22
23 4 th Generation Testing Confirmatory Testing IA Positive Multispot Confirmatory Multispot Can Detect HIV-1 and HIV-2 Quickly identifies Ab+ (including those WB -) Confirmatory Testing IA positive Multispot negative Conduct Nucleic Acid Amplification Test (NAAT) Looks for actual virus (HIV-1 RNA) Reduces window period to 1 to 2 weeks Blood only 23
24 Targeted Testing: New Directions What does HIV testing look like in terms of HIP? New CDC requirements regarding seropositivity rates (1% minimum, Cat. A) Populations to test (MSM, serodiscordant couples, black/hispanic, etc.) 24
25 Targeted Testing, cont. Incorporate additional tests when possible (e.g., STD, Hepatitis) Low impact vs. high impact testing? When new positives are identified, linkage is KEY 25
26 Testing in Medical Settings Building partnerships/collaborations Potential collaborations/sites 26
27 Social Network Strategy (SNS) CDC Model (researched, showed evidence of effectiveness) Social Networks is a recruitment strategy designed to increase HIV testing among high-risk populations by using their existing social networks. Recruiters refer the social, sexual, and drug using members of their social network to HIV counseling and testing services. Network associates are the members referred by recruiters. 27
28 Social Networks Strategy (SNS) It is designed to reach those individuals who would not normally seek HIV CTL services. SNS is based on relationships, trust, and incentives. Population MUST share common risk behaviors and risk factors in order for SNS to work to its full potential (i.e., find the most positives as possible). Examples include: young black MSM (ages 18-29) on HBCU campus, sex workers on OBT, IDUs, etc. 28
29 Florida s HIV Testing Initiatives Expanded Testing Initiative (ETI) Citywide Testing Awareness Campaigns (Miami, Orlando, Palm Beach, Tampa Bay, Broward is Greater than AIDS) 112,000 by 2012 (Latino Testing Initiative) SOS 29
30 Expanded Testing Initiative (ETI) 12 counties Focus is on testing populations with highest burden of HIV Black and Hispanic heterosexuals MSM, IDU of all races and ethnicities Transgender populations 70% of funding to testing in healthcare settings 30
31 Bus Placards 31
32 Mobile Billboard 32
33 Citywide Testing Awareness Campaigns Take Control Events, Miami Test Miami, Broward is Greater than AIDS, Test Orlando, Test Tampa Bay, Test Palm Beach County 33
34 112,000 Latinos in 2012 Seeks to respond to HIV crisis by uniting Latino leaders, businesses, churches, CBOs and others in FL to act and fight against the spread of HIV. The goal is to increase and normalize HIV testing in all Latino communities throughout the state by testing 112,000 Latinos by the end of
35 Sistas Organizing to Survive SOS Grassroots mobilization initiative for black women, launched in June 2008 Encourages black women to get tested where they live, work, play, and worship Original goal was to test 100,000 black women each year by
36 What s the Take-home? Know who you need to reach Know where you need to reach them Repeat testing for high-risk populations 36
37 Webinar Evaluation Before you leave the webinar, please take a moment to complete the evaluation in the polling section (to the right of your screen) Your feedback is extremely important to us and will help improve on current and future trainings The more feedback the better! 37
38 Resources High Impact Prevention: CDC s Approach to Reducing HIV Infections in the United States National HIV/AIDS Strategy FL HIV Prevention Section Website (slides from today s webinar will be available here, under Resources & Materials) Testing Page, FL HIV Prevention Section (rapid testing guidelines, forms, data, training schedules) FL Bureau of HIV/AIDS and Hepatitis Website Social Networks Testing: A Community-based Strategy for Identifying Persons with Undiagnosed HIV Infection, CDC, Atlanta, GA Duran, D., Beltrami, J., Stein, R., Voetsch, A., & Branson, B. (August 2008). Persons Tested for HIV, MMWR, 57(31); Campsmith, ML, Rhodes, P, Hall, HI, & Green, T. (October 2008). HIV Prevalence Estimates- United States, MMWR, 57(39); Hall, IH, Song, R, Rhodes, P, Prejean, J, An, Q, Lee, LM, Karon, J, Brookmeyer, R, Kaplan, EH, McKenna, MT, & Janssen, RS. (2008). Estimation of HIV Incidence in the United States. JAMA, 300(5);
39 Questions/Comments 39
40 Contact Information Tom Bendle Testing Team Lead Bureau of HIV/AIDS, Prevention Section Florida Department of Health 4052 Bald Cypress Way, Bin A-09 Tallahassee, FL (850) Visit us online at:
Understanding the HIV Care Continuum
Understanding the HIV Care Continuum Overview Recent scientific advances have shown that antiretroviral therapy (ART) not only preserves the health of people living with HIV, but also dramatically lowers
Estimates of New HIV Infections in the United States
Estimates of New HIV Infections in the United States Accurately tracking the HIV epidemic is essential to the nation s HIV prevention efforts. Yet monitoring trends in new HIV infections has historically
Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results
Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results David W. Forrest, Ph.D. Marlene LaLota, M.P.H. John-Mark Schacht Gabriel A. Cardenas, M.P.H. Lisa Metsch, Ph.D. National HIV Behavioral
SMART Objectives & Logic Modeling. HIV Prevention Section Bureau of HIV/AIDS
SMART Objectives & Logic Modeling HIV Prevention Section Bureau of HIV/AIDS Typing a Question in the Chat Box Type question in here Completing the Webinar Evaluation (opened at end of webinar) SMART Objectives
Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care
Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care Anna Satcher Johnson, MPH Symposium on Measuring the HIV Care Continuum Center for AIDS Research University of Washington
HPTN 073: Black MSM Open-Label PrEP Demonstration Project
HPTN 073: Black MSM Open-Label PrEP Demonstration Project Overview HIV Epidemiology in the U.S. Overview of PrEP Overview of HPTN HPTN 061 HPTN 073 ARV Drug Resistance Conclusions Questions and Answers
Case Finding for Hepatitis B and Hepatitis C
Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center
HIV Surveillance Update
HIV Surveillance Update Presentation to: CAPUS Metro Atlanta Testing and Linking Consortium (MATLC) Presented by: Deepali Rane, MPH and Jane Kelly, MD Georgia Department of Public Health Epidemiology Date:
A Ministry of the Archdiocese of Galveston-Houston A United Way Agency
A Ministry of the Archdiocese of Galveston-Houston A United Way Agency Integrated Multidsciplinary Approach to Adapt Routine HIV Screening in a Safety Net Clinic Setting Sherri D. Onyiego MD, PhD Baylor
DC Comprehensive HIV Prevention Plan for 2012-2015: Goals and Objectives
DC Comprehensive HIV Prevention Plan for 2012-2015: Goals and Objectives The Comprehensive Plan includes program goals and objectives, monitoring and evaluation, and capacity building activities specific
Illustrating HIV/AIDS in the United States
Illustrating HIV/AIDS in the United States Black Persons 2013 Update About AIDSVu AIDSVu is a compilation of interactive, online maps that allows users to visually explore the HIV epidemic in the U.S.
Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services
Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services ADP Training Conference, Sacramento, August 21, 2012 Rachel McLean, MPH, CA Dept. of Public
2014-2016 ALAMEDA COUNTY, CALIFORNIA COMPREHENSIVE HIV PREVENTION PLAN
2014-2016 ALAMEDA COUNTY, CALIFORNIA COMPREHENSIVE HIV PREVENTION PLAN JULY 2014 Prepared by the Oakland TGA Collaborative Community Planning Council HIV Prevention Committee & the Alameda County Office
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center
The HIV/AIDS Epidemic in California s Latino Population
The HIV/AIDS Epidemic in California s Latino Population Barbara Bailey, M.S. Acting Chief Office of AIDS California Department of Health Services www.dhs.ca.gov/aids AIDS Incidence (Cases per 100,000)
Department of Veterans Affairs National HIV/AIDS Strategy Operational Plan 2011
Department of Veterans Affairs National HIV/AIDS Strategy Operational Plan 2011 Table of Contents Purpose..3 Overview of HIV Health Care.....4 Goal 1: Reducing the Number of People who become infected
Suggested Reporting Language for the HIV Laboratory Diagnostic Testing Algorithm
Suggested Reporting Language for the HIV Laboratory Diagnostic Testing Algorithm November 2013 Introduction In March 2010, the Centers for Disease Control and Prevention (CDC) and the Association of Public
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report 2008. Sweden
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS Country Progress Report 2008 Sweden ABBREVIATIONS...3 ACKNOWLEDGEMENTS...4 STATUS AT A GLANCE...1 NATIONAL INDICATOR DATA... 2 OVERVIEW OF THE
in hiv diagnostics the role of phls
Issues in Brief: HIV Diagnostics UPDATE Association of Public Health Laboratories August 2011 Conference calls Focus on New trends in hiv diagnostics the role of phls In February 2011, the Association
Australian Federation of AIDS Organisations (AFAO) Primary Health Care Reform
Australian Federation of AIDS Organisations (AFAO) Primary Health Care Reform 27 February 2009 1 Introduction The Australian Federation of AIDS Organisations (AFAO) is the peak body for Australia s community
HIV and AIDS in Bangladesh
HIV and AIDS in Bangladesh BACKGROUND The first case of HIV/AIDS in Bangladesh was detected in 1989. Since then 1495 cases of HIV/AIDS have been reported (as of December 2008). However UNAIDS estimates
Substance Abuse Treatment Evaluations and Interventions Program
Substance Abuse Treatment Evaluations and Interventions Program Project Highlights: HIV Interventions in North Carolina Wendee Wechsberg, Ph.D. SATEI Program Director RTI International 3040 Cornwallis
Who gets tested and where: Patterns of HIV testing among MSM Jennifer L. Lauby, PhD Public Health Management Corporation Philadelphia, PA HIV testing services need to: Find ways to reach and test MSM who
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Age Differences in Viral Suppression, Antiretroviral Therapy Use, and Adherence Among HIV-positive Men Who Have Sex With Men Receiving
GAO INDIAN HEALTH SERVICE. HIV/AIDS Prevention and Treatment Services for American Indians and Alaska Natives. Report to Congressional Requesters
GAO United States Government Accountability Office Report to Congressional Requesters December 2007 INDIAN HEALTH SERVICE HIV/AIDS Prevention and Treatment Services for American Indians and Alaska Natives
The Florida Department of Health in Broward County Addresses HIV Care Linkage, Retention, and Adherence
The Florida Department of Health in Broward County Addresses HIV Care Linkage, Retention, and Adherence Abraham Feingold, Psy.D. Florida Department of Health in Broward County Where We Work Where We Play
2012 2014 Maryland HIV Plan
Maryland Department of Health & Mental Hygiene Prevention and Health Promotion Administration 2012 2014 Maryland HIV Plan Comprehensive HIV Plan Statewide Coordinated Statement of Need Maryland HIV Prevention
Project AWARE Study Overview. Lisa Metsch, PhD Grant Colfax, MD Dan Feaster, PhD
Project AWARE Study Overview Lisa Metsch, PhD Grant Colfax, MD Dan Feaster, PhD January 9, 2012 Two Testing Strategies Evaluated in 2-arm RCT On-site HIV rapid testing (via fingerstick) with brief participant-tailored
STATE OF THE HIV/AIDS EPIDEMIC IN CHARLESTON
STATE OF THE HIV/AIDS EPIDEMIC IN CHARLESTON 12/1/2015 A Crisis Among Lowcountry Youth The Charleston region is facing a serious issue of rising HIV rates, particularly among those under the age of 30.
EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE ELIGIBLE METROPOLITAN AREA PLANNING, PHILADELPHIA
EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE PLANNING, PHILADELPHIA ELIGIBLE METROPOLITAN AREA 2015 Prepared for the Philadelphia Eligible Metropolitan Area Ryan
HIV/AIDS: General Information & Testing in the Emergency Department
What Is HIV? HIV/AIDS: General Information & Testing in the Emergency Department HIV is the common name for the Human Immunodeficiency Virus. HIV is a retrovirus. This means it can enter the body s own
HIV prevention and the wider UK population. What HIV prevention work should be directed towards the general population in the UK?
Shaping attitudes Challenging injustice Changing lives Policy briefing HIV prevention and the wider UK population September 2011 What HIV prevention work should be directed towards the general population
HIV Epidemiology in New York State
HIV Epidemiology in New York State Lou Smith, MD, MPH Director, Division of Epidemiology, Evaluation and Research AIDS Institute, New York State Department of Health 2 HIV Surveillance in New York State
Richard H. Needle, PhD, MPH Lin Zhao, PhD candidate (UCSF School of Nursing) CSIS Africa Program Roundtable June 10, 2010
Richard H. Needle, PhD, MPH Lin Zhao, PhD candidate (UCSF School of Nursing) CSIS Africa Program Roundtable June 10, 2010 Reference Group to the United Nations on HIV and Injecting Drug Use 2010 Mathers:
Chapter 1 Overview of Tuberculosis Epidemiology in the United States
Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States.... 3 TB Disease Trends in the United
How To Prevent An Std
As is true of other racial health disparities, the disproportional prevalence of STDs among American Indians does not reflect any biological difference in infection susceptibility, but rather inequalities
Health Care Access to Vulnerable Populations
Health Care Access to Vulnerable Populations Closing the Gap: Reducing Racial and Ethnic Disparities in Florida Rosebud L. Foster, ED.D. Access to Health Care The timely use of personal health services
Michael N. Joyner Director, Positive Action and Patient Advocacy. ViiV Healthcare
Michael N. Joyner Director, Positive Action and Patient Advocacy ViiV Healthcare When Positive Action was created in 1992 it was the first pharmaceutical company program of its kind to support communities
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network [email protected] August 13, 2015 1400 EDT (2:00 PM EDT) NH-HAN 20150813 Updated Centers for Disease Control (CDC)
HARM REDUCTION FOR PEOPLE WHO INJECT DRUGS INFORMATION NOTE
HARM REDUCTION FOR PEOPLE WHO INJECT DRUGS INFORMATION NOTE Introduction The Global Fund supports evidence-based interventions that aim to ensure access to HIV prevention, treatment, care and support for
City of Los Angeles, 2003-2008 Consolidated Plan
, 2003-2008 Consolidated Plan D. Other Special Needs Supportive and Housing Services The Mayor has identified residents with special needs as a top priority for the Consolidated Plan and Annual Action
Guidelines for Viral Hepatitis CTR Services
Guidelines for Viral Hepatitis CTR Services During the 2007 North Dakota Legislative Assembly, legislation that called for the creation of a viral hepatitis program was introduced and approved. The North
HIV/AIDS PAPER OUTLINE. 0.Introduction. -Definitions. 1. AIDS as a stigma. -Factors to the AIDS stigma. 2. Transmission to HIV
HIV/AIDS PAPER OUTLINE 0.Introduction -Definitions 1. AIDS as a stigma -Factors to the AIDS stigma 2. Transmission to HIV - The most common ways that people get HIV 3. Where you can not get AIDS 4. Conclusion
HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline
HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline Background... 2 Screening... 2 Recommendations... 2 Ordering and consent... 2 Indications for Periodic HIV Screening...
Dallas National HIV Behavioral Surveillance System 2009 Annual Data Report Injection Drug Use
Dallas National HIV Behavioral Surveillance System 2009 Annual Data Report Injection Drug Use May 2012 HIV Information and Projects Group TB/HIV/STD Epidemiology and Surveillance Branch Texas Department
The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011
The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011 Section 5: Screening, Treating and Reporting Chlamydia While the information
Preface. TTY: (888) 232-6348 or [email protected]. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636)
Preface The purpose of this CDC Hepatitis C Counseling and Testing manual is to provide guidance for hepatitis C counseling and testing of individuals born during 1945 1965. The guide was used in draft
Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers
Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers James Wilton Coordinator, Biomedical Science of HIV Prevention
Injecting Drug Use and Youth: PSI s Programs. Shimon Prohow HIV Department Population Services International
Injecting Drug Use and Youth: PSI s Programs Shimon Prohow HIV Department Population Services International PSI and HIV Male and Female Condoms HIV Counseling and Testing Male Circumcision Tuberculosis
Viral Hepatitis Case Report
Page 1 of 9 Viral Hepatitis Case Report Perinatal Hepatitis B Virus Infection Michigan Department of Community Health Communicable Disease Division Investigation Information Investigation ID Onset Date
HIV/AIDS Epidemiology Report
HIV/AIDS Epidemiology Report 2012 County of San Diego Health and Human Services Agency Division of Public Health Services Epidemiology and Immunization Services Branch HIV/AIDS Surveillance Program Epidemiology
PLUS MAY EQUAL. Flu-Like Symptoms SORE THROAT, SWOLLEN GLANDS, FEVER, JOINT AND MUSCLE ACHES
What is acute HIV infection? Acute HIV infection is the very early stage of infection with HIV (human immunodeficiency virus), the virus that causes AIDS. This is also called primary HIV infection. Acute
HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016
HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016 Daily emtricitabine/tenofovir (Truvada ) is safe and effective for reducing the risk of HIV acquisition in sexually
How To Reduce High Risk Behavior In Injection Drug Users Through Syringe Exchange
Alex Willard HWP 455.002 Research Paper November 17, 2010 Reducing High Risk Behavior in Injection Drug Users Through Syringe Exchange For prevention of transmission of the Human Immunodeficiency Virus
Minnesota HIV/AIDS Epidemiologic Profile
Minnesota HIV/AIDS Epidemiologic Profile DECEMBER 2015 Executive Summary Abbreviations Used AIDS Acquired Immune Deficiency Syndrome ADAP AIDS Drugs Assistance Program CCCHAP Community Cooperative Council
Perspective Implications of the Affordable Care Act for People With HIV Infection and the Ryan White HIV/AIDS Program: What Does the Future Hold?
Perspective Implications of the Affordable Care Act for People With HIV Infection and the Ryan White HIV/AIDS Program: What Does the Future Hold? There are numerous aspects of the Patient Protection and
Implementing HCV Screening into Federally Qualified Health Centers. Donna Brian, PhD, CRNP Catelyn, Coyle MEd
Implementing HCV Screening into Federally Qualified Health Centers Donna Brian, PhD, CRNP Catelyn, Coyle MEd Background Public Health Management Corporation (PHMC): Public health Institute located in Philadelphia
2012-2015 STRATEGIC PLAN TO ADDRESS HIV IN IOWA
SECTION 3. 2012-2015 STRATEGIC PLAN TO ADDRESS HIV IN IOWA This final section of the Iowa Comprehensive HIV Plan contains recommendations for a cascade of prevention and care activities that are designed
Coding and Billing for HIV Services in Healthcare Facilities
P a g e 1 Coding and Billing for HIV Services in Healthcare Facilities The Hawai i State Department of Health STD/AIDS Prevention Branch is pleased to provide you information on billing and reimbursement
Placing Nation on the Path Toward the Elimination of Hepatitis C
Placing Nation on the Path Toward the Elimination of Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Division of Viral Hepatitis National Center for
Hepatitis C Infections in Oregon September 2014
Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with
Adelbert B. James, PhD, MPH
307 Andridge Court Cell: 678-699-1612 Suwanee, GA 30024 Email: [email protected] EDUCATION: PhD Health Services, specializing in Community Health, Walden University, Minneapolis, MN 2003 Graduate
XVIIth International Aids Conference, Mexico City
XVIIth International Aids Conference, Mexico City 5 August 2008 Parliamentary Briefing on HIV/AIDS: parliamentarians as partners in the fight against HIV. Prof. Dr. Marleen Temmerman, Senator, Belgian
FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT
FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT What is the purpose of this report? The purpose of this report is to present the administrative policies and clinical guidelines for the
HIV-Associated Risk Behaviour Among Drug Users at Drug Rehabilitation Centres
, ORIGINAL ARTICLE HIV-Associated Risk Behaviour Among Drug Users at Drug Rehabilitation Centres M N Fauziah, MD, S Anita, MD, B N Sha'ari, MD, B I RosH, MD Introduction HIV infection and AlDS is a major
Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013
Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013 On July 16, 2012, the Food and Drug Administration (FDA) approved
Gay and Lesbian Activists Alliance of Washington, DC 2015 Questionnaire for D.C. Council Candidates. Brandon Todd, Democrat, Ward 4 Council Candidate
1 Gay and Lesbian Activists Alliance of Washington, DC 2015 Questionnaire for D.C. Council Candidates Brandon Todd, Democrat, Ward 4 Council Candidate HOME RULE 1. If Congress acts to block recent bills
Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid
Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.
